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article under the CC BY-NC-ND licenseAbstract Objective: A major role in the establishment of computer-assisted robotic surgery
(CARS) can be traced to the work of Mani Menon at Vattikuti Urology Institute (VUI), and of
many surgeons of Asian origin. The success of robotic surgery in urology has spurred its accep-
tance in other surgical disciplines, improving patient comfort and disease outcomes and help-
ing the industrial growth. The present paper gives an overview of the progress and
development of robotic surgery, especially in the field of Urology; and to underscore some
of the seminal work done by the VUI and Asian surgeons in the development of robotic surgery
in urology in the US and around the world.
Methods: PubMed/Medline and Scopus databases were searched for publications from 2000
through June 2014, using algorithms based on keywords “robotic surgery”, ”prostate”, “kid-
ney”, “adrenal”, “bladder”, “reconstruction”, and “kidney transplant”. Inclusion criteria used
were published full articles, book chapters, clinical trials, prospective and retrospective se-
ries, and systematic reviews/meta-analyses written in English language. Studies from Asian in-
stitutions or with the first/senior author of Asian origin were included for discussion, and
focused on techniques of robotic surgery, relevant patient outcomes and associated demo-
graphic trends.
Results: A total of 58 articles selected for final review highlight the important strides made by
robots in urology, from robotic radical prostatectomy in 2000 to robotic kidney transplant in
2014. In the hands of an experienced robotic surgeon, it has been demonstrated to improve
functional patient outcomes and minimize perioperative complications compared to open sur-
gery, especially in urologic oncology and reconstructive urology. With increasing surgeon pro-
ficiency, the benefits of robotic surgery were consistently seen across different surgical
disciplines, patient populations, and strata.(D. Dalela).
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2 D. Dalela et al.Conclusion: The addition of robot to the surgical armamentarium has allowed better patient
care and improved disease outcomes. VUI and surgeons of Asian origin have played a pioneer-
ing role in dissemination of computer-assisted surgery.
ª 2015 Editorial Office of Asian Journal of Urology. Production and hosting by Elsevier
(Singapore) Pte Ltd. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).“If you always do what you always did, you will always
get what you always got.”-Albert Einstein1. Introduction
When Dr Tom Lue asked us to chronicle the contribution of
Vattikuti Urology Institute (VUI) in the field of robotic surgery,
we knew we had two unique opportunities: one, to describe
the development and progress of robotic surgery, and two, to
convey the subliminal message of how VUI and urologists of
Asian descent were instrumental in that process.
The foundation for robotic surgery was laid when Dr Mani
Menon, then Chief of Department of Urology at Henry Ford
Hospital (HFH), Detroit, USA set out to start an ambitious
minimally invasive prostatectomy program at his center in
1999e2000. He set up a formal collaboration with the
French group of Drs Vallancien and Guillonneau at Mon-
tsouris (the then leaders in laparoscopic prostatectomy),
but was disillusioned with the inferior results and the
cumbersome, counterintuitive approach of laparoscopy. It
was somewhat serendipitous when the Food and Drug
Administration (FDA), in the year 2000, approved the da
Vinci robot for soft-tissue surgery. Even though its accep-
tance rate was rather slow in cardiac surgery (the initial
raison d eˆtre for the robot), it seemed to fill the voids in
laparoscopy. There was minimal literature on its use in
prostatectomy at the time when da Vinci was incorporated
in HFH program. The first robot-assisted radical prostatec-
tomy (RARP) was performed at HFH on November 29, 2000.
Experience with laparoscopic and robotic prostatectomy
accumulated quickly. A series of 50 RARPs performed at
HFH was published in 2002 [1]. The rest is history.
While progression from radical prostatectomy to other
pelvic surgeries was natural progression, robotic upper
tract surgery evolved in parallel. Reconstructive techniques
involved in these procedures were defined and refined.
Robotic procedures in female and pediatric urology were
planned and executed. Methods were adopted to safely
transfer new surgical procedures from mere ideas to bench,
and then to operating rooms.
In this review, we look back at the fascinating 15-year
robotic journey from radical prostatectomy in 2000 to renal
recipient surgery in 2014.2. Evidence acquisition
2.1. Search strategy
A literature search was performed using PubMed/Medline and
Scopus databases to identify the important publicationspertaining to robotic surgery (predominantly in urology) from
January 1, 2000 through June 1, 2014. Two search algorithms
were used. In the first search strategy, we sequentially com-
bined the keyword “robotic surgery” with “prostate”, “kid-
ney”, “adrenal”, “bladder”, “reconstruction”, using the AND
operator for each pair of keywords, to identify publications
relating to the application of robotics in prostate, kidney,
bladder, adrenal, and reconstructive urology, respectively.
The second searchwasperformedusing the samecombination
of keywords but with the NOT operator, to identify the
important non-urological publications of robotic surgery. In-
clusion criteria used were published full articles, book chap-
ters, clinical trials, prospective and retrospective series, and
systematic reviews/meta-analyses written in English lan-
guage. Next, results were screened according to the origi-
nating institution and the nationality of the first and/or senior
author. Studies from Asian institutions or with the first/senior
authorofAsianoriginwere includedfordiscussion (Fig. 1).The
same search criterion was used for both the databases.
Additional publications have been used to substantiate
statement origins and help description as necessary.
2.2. Study selection
Included studies focusedononeormoreof the followingareas:
development/description of novel robotic surgical tech-
niques, standardization/validation of a robotic surgical tech-
nique, important modifications in pre-existing surgical
technique resulting in demonstrable benefit in patient out-
comes, comparison of perioperative, short- or long-term out-
comes of robotic vs. laparoscopic or open surgical approaches,
and demographic and population trends associated with
acceptance of robotic surgery. Although there was a prepon-
derance of urological literature, a few important studies from
other surgical specialties were also studied and discussed to
highlight the position of robotic surgery in the said specialty.
2.3. Review methods
A total of 58 studies were included in the review, after
preliminary screening of abstracts and exclusion of dupli-
cate results. The searches were performed jointly by two
co-authors (RA and DD), and a consensus on the relevance
of the publication was arrived on by mutual discussion.
3. Evidence synthesis
3.1. Robotic prostatectomy
Dr Menon started the robotic prostatectomy program at the
VUI at HFH in March 2001. Over the next few months, the
Figure 1 The selection of articles for review.
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be known as the Vattikuti Institute Prostatectomy (VIP) [2].
Initial observations demonstrated the benefit of VIP over
open or laparoscopic counterparts for all perioperative
parameters, operating room time, estimated blood loss
(EBL), complications, catheterization time and hospital
length of stay (LOS) >24 h [1,3]. Median time to continence
and postoperative PSA levels were lowest for VIP. Better
vision and robotic dexterity improved functional outcomes
of continence and potency too.
Anatomic studies further showed that the neurovascular
tissue is not confined to the “bundle”, but is wider and
spread over, intimately related to the anterolateral surface
of the prostatic fascia [4,5]. We hypothesized that devel-
oping a high anterior plane between the prostatic capsule
and the inner periprostatic fascial layer could potentially
allow for greater nerve preservation [6]. The preserved
neurovascular tissue, a remnant of interfascial dissection
between 1 o’ clock and 5 o’ clock position and between
7 o’ clock and 11 o’ clock position, was eponymously termed
“veil of Aphrodite”. Prospective comparison of bilateral
“veil” technique with bilateral standard nerve sparing in
men with localized prostate cancer and normal baseline
erectile function showed significantly better recovery of
erections (Sexual Health Inventory for Men [SHIM] >21 in
86% vs. 26%, p < 0.0001) and higher percentage of erections
firm enough for intercourse (97% vs. 74%, p Z 0.002) at 12
months after surgery [7]. Further preserving the fibers lying
between 11 o’ clock and 1 o’ clock position of the prostate
(along with the puboprostatic ligaments and the dorsal
venous complex) formed the basis for the “super veil”
procedure, which could be offered to men with low risk
disease. A comparison of consecutive cases with the “veil”
and the “super veil” procedure showed a faster return to
erectile function with the latter [8].
We started performing double-layered urethrovesical
anastomosis (UVA) to combine the claimed beneficial roles
of posterior rhabdosphincter reconstruction [9], and lateral
and anterior reconstruction [10], expecting a faster return
of continence. However, randomized trials at our centerfailed to show any advantage of double layered UVA on
early (<30 d) continence recovery [11] or long-term (2
year) continence rates [12]. We, however, adopted this
technique as a standard of care owing to the decreased
incidence of cystographic leaks compared to the single
layer UVA (3.4% vs. 8.8%, p < 0.05).
A running UVA with monofilament suture has a tendency
to slip, leading to increased anastomotic time and the
annoying need to tighten the suture after every couple of
throws. FDA approved the polyglyconate self-anchoring
barbed suture for soft-tissue approximation in 2010. We
fashioned it into a double-armed stitch for UVA [13] with
barbs directed in different directions from the center. It
minimized slippage and revision of throws by the console
surgeon, while overcoming the need to “follow” and retract
the suture by the assistant. Comparison of patients under-
going VIP with the barbed vs. the standard monofilament
suture showed a 26% reduction in total anastomotic time
without compromising outcome [14].
Urethral catheter is disliked by most patients, and is a
cause of discomfort and bladder spasms postoperatively,
requiring anticholinergics. We explored the option of replac-
ing the urethral catheter with percutaneous suprapubic tube
and observed significantly less catheter-related discomfort,
and need for anticholinergic medications [15]. Absence of
postoperative urethral catheter did not increase bladder neck
contractures, and reduced risk of urethral stricture or meatal
stenosis [16]. That said, a watertight anastomosis and excel-
lent mucosal apposition is a sine qua non for safely circum-
venting the need for a urethral catheter.
The need and optimal extent of pelvic lymphadenec-
tomy to be performed in patients with low-risk prostate
cancer (Gleason 3 þ 3/3 þ 4, T1c, PSA < 10 ng/mL) has
generated significant debate. We modified our template to
include internal iliac group of nodes (zone 2), shown to be
the commonest site of metastases [17], to standard
external iliac and obturator node dissection (zone 1). Pa-
tients that had zone 2 dissection had a 13.7 times higher
incidence of positive nodal yield than patients with zone 1
dissection only [18].
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with a minimum 5-year follow-up (the largest number ever
reported with the longest follow-up) demonstrated an
overall actuarial biochemical recurrence free survival
(BCRFS) of 84% [19]. The quality of VIP improved with time,
with significant reduction in mean console time (97 vs.
121 min, p < 0.05) and positive surgical margin (PSM) rate
for organ-confined disease (4% vs. 7%, p < 0.05), although
more patients with aggressive disease and prior abdominal
surgery underwent VIP. A recent analysis of the oncological
outcomes in 4803 patients after a mean follow-up of 34.6
months continues to demonstrate encouraging results, with
actuarial 8-year BCRFS, metastases-free survival and can-
cer specific survival being 81%, 98.5% and 99.1%, respec-
tively [20]. Multi-institutional collaboration between
different surgeons from USA and Europe (like Dr Mani
Menon, Dr Ashutosh Tewari, Dr Vipul Patel, and Dr Prasanna
Sooriakumaran, to name a few) helped to formulate
guidelines to achieve the ideal “trifecta” of outcomes
(cancer control, potency and continence) [21e24]. Com-
parison of outcomes of open radical prostatectomy vs.
RARP in the post-dissemination era found RARP to have
lower 90-d overall rates of wound, respiratory, miscella-
neous surgical and medical complications (all p < 0.04),
lower postoperative transfusion rates and LOS (both
p < 0.001) [25]. RARP resulted in significantly lesser PSM
(even in intermediate and high-risk cases) and need for
secondary cancer treatment at 6, 12 and 24 months after
surgery [26].
Recently, we described the “ICE” technique (Intra-
Corporeal cooling and Extraction) for VIP, which allows
bimanual examination of the prostate, frozen section bi-
opsies, and introduction of ice-slush for pelvic hypother-
mia, using the GelPointª access platform [27]. We expected
bimanual palpation and appropriate biopsies to reduce
PSM, while pelvic cooling would limit the inflammatory
damage to the pelvic neurovasculature during surgical
trauma and help preserve potency and continence post-
operatively. Compared to patients undergoing conventional
prostatectomy, bimanual examination reduced the abso-
lute risk of PSM by 26.6% in pT3a patients (p Z 0.04).
Impact of regional pelvic hypothermia on return of conti-
nence is currently being prospectively evaluated.
3.2. Robotic cystoprostatectomy
Menon et al. [28] published their pioneering robot-assisted
radical cystoprostatectomy (RARC) series of 17 cases in
2003. Robotic interface provides a safer cystectomy by
reducing blood loss and fluid shifts, and avoiding bowel
exposure and handling. A less edematous bowel may, thus,
be available for post cystectomy diversion, resulting in
earlier return of bowel function and decreased length of
hospital stay. The described technique by Menon et al. [28]
involved nerve-sparing RARC using the principles learnt
from the prostatectomy experience, with minimal blood
loss. The 5e6 cm suprapubic incision, made for cys-
toprostatectomy specimen removal, was used to create a
neobladder extracorporeally. The created pouch was
internalized, and the neo-vesicourethral anastomosis
completed with robotic assistance after closure of incision.Overall margin positive rates of under 7%, 1.6% for T2 dis-
ease, are equivalent to published PSM rates of 4%e6% with
ORC [29,30].
ORC has a 90-day complication rate of 64% using a
standardized reporting methodology, although only 13% of
these were Clavien grade 3 to 5. Reoperation was required
in 3%, and 11% needed radiologic intervention. Mortality
rate was 1.5% [31]. Median blood loss during ORC was 1 L,
and two thirds of patients required a blood product trans-
fusion. Using similar reporting format, Guru and coworkers
[32] reported comparable postoperative complication and
reoperation rates for RARC, with significantly lesser blood
loss (400 mL) and need for transfusion (16%). For a matched
cohort, there is quicker recovery of bowel function and
convalescence following RARC compared to ORC, with
equivalent oncological outcome and reduced complications
at short and intermediate follow-up [33,34].
With the limited diagnostic capability of CT and MRI for
LN staging [35] and evidence to show that extended lym-
phadenectomy may improve long-term survival and prog-
nosticate the outcome in patients with muscle invasive
bladder cancer [36], the role of surgical lymphadenectomy
became increasingly more important. There were doubts
about robotic lymphadenectomy techniques to raise lymph
node yields similar to open methods, as well as capability to
replicate the technique at other centers. A multi-
institutional cystectomy database, International Robotic
Cystectomy Consortium (IRCC), was created for the pur-
pose. Using this large multi-institutional cohort database
with approximately 450 lymphadenectomies, yield of lym-
phadenectomy at robotic cystectomy was shown to be
similar to those of open cystectomy series, obtaining a
mean of 18 lymph nodes [37]. Further, MD Anderson Cancer
Center series had a robotic lymph node yield of 43, with an
efficiency of 93%. There was no residual lymphatic tissue in
80% cases on open “second look” lymphadenectomy [38].
The finding is not surprising considering the degree of vessel
mobilization and the views available with the robot.
Although initial technique of RARC described by Menon
et al. [28] involved exteriorization of bowel through the
specimen retrieval wound for extracorporeal suturing
before dropping it back for robotic neo-vesicourethral
anastomosis, it gradually turned intracorporeal with ro-
botic suturing dexterity as well as developing stapling de-
vices. Multi-centric IRCC data for 90 day postoperative
follow-up has recently been published, comparing 167
intracorporeal (ileal conduit: 106; neobladder: 61) to 768
extracorporeal diversions (ileal conduit: 570; neobladder:
198). The operative time (414 min) and median hospital
stay (9 days intracorporeal vs. 8 days extracorporeal) were
comparable, as were reoperation rates (within 30 days) and
complication rates (90 days). As expected with less bowel
handling, gastrointestinal complications were significantly
less in the intracorporeal group [39].
3.3. Robotic upper tract and renal surgery
The advent of the robotic platform transformed the realm
of upper tract surgery too. Robotic kidney surgery program
was developed at VUI simultaneous to the pelvic surgery.
Robotic nephrectomies were started in January 2004. A
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radical nephrectomy) showed a mean operative console
time of 158 min, mean EBL 223 mL and a mean LOS of 2.4
days. There was no evidence of recurrence at a mean
follow-up of 15.7 months [40]. We showed the feasibility of
robotic extended pyelolithotomy in 13 patients with stag-
horn calculi with a mean operative time of 158 min, mean
console time 108 min, and EBL 100 mL, achieving stone free
status in all but one patient [41]. Eun et al. [42] described a
four-port “baseball diamond” strategy of port placement
for patients undergoing nephroureterectomy to allow in-
strument access to the ipsilateral upper and lower urinary
tract in the same operative session, without repositioning
the patient and re-docking the robot. Utilizing the robotic
magnification and precision in movement for microdissec-
tion of anatomical planes around the adrenal gland, a four-
step technique of robotic right adrenalectomy [43] and
synchronous bilateral adrenalectomy [44] were described.
Helped with some revealing data of laparoscopic partial
nephrectomy from Cleveland Clinic, Gill et al. [45] and Ng
et al. [46] had established the feasibility of minimally
invasive partial nephrectomy using laparoscopy. The steep
learning curve of laparoscopy combined with working under
the pressure of a limit of warm ischemia time (WIT), un-
fortunately, limited the use of this minimally invasive
platform to select centers only, much like laparoscopic
prostatectomy. Efforts had started to develop and refine
robot-assisted partial nephrectomy (RAPN) techniques.
With minimally invasive partial nephrectomy (PN) becoming
the standard of care for renal tumors <4 cm in size, we
published our initial experience of RAPN in 10 patients with
mean tumor size of 2 cm [47]. In order to improve minimally
invasive surgical skills, we devised novel laboratory models
for solid renal tumor (“pseudotumor”) and renal vein tumor
thrombus (“pseudothrombus”) in pigs and cadavers [48].
The robotic technique allowed precise resection and hel-
ped perform pelvicaliceal system closure and renorrhaphy,
without unduly increasing the warm ischemia time [49].
Techniques of RAPN were continuously refined. In 2009,
we illustrated our four-arm technique of RAPN using a
transperitoneal approach, highlighting the role of the
fourth arm in renal hilar dissection, vascular control and
during renorrhaphy [50]. The Tile-Pro feature of the da
Vinci allowed visualization of intraoperative USG and pre-
operative CT images as a picture-on-picture image on the
console screen to aid tumor margin identification [51].
Development of robotic bulldog clamps and intraoperative
ultrasound probes gave further functional autonomy to the
console surgeon, reducing his dependence on the variably
skilled patient-side assistant [52,53]. The first report on the
single-surgeon, single-center experience of RAPN for renal
tumors was published from VUI, comparing T1a with larger
tumors, and found equivalent EBL, total operative time,
LOS, complication rates and change in estimated glomer-
ular filtration rate (eGFR) in the two groups [54]. Multi-
institutional series later confirmed our results even for
more complex tumors [55] and in obese patients [56].
Various techniques for minimally invasive PN, like sliding
clip renorrhaphy and early unclamping, appeared in an
effort to reduce warm ischemia. Encouraged with the suc-
cess of UVA with barbed suture during VIP, we established
its safety and feasibility of a two-layered, running closureof the collecting system and renal capsule during renor-
rhaphy, and significantly lowering WIT compared to stan-
dard polyglactin suture (18.5 vs. 24.7 min, respectively,
pZ 0.008) [57]. As regional hypothermia would expand the
window for duration of permissible ischemia, we success-
fully experimented with the GelPoint access platform to
introduce ice-slush. With a mean cold ischemia time of
19.6 min and mean EBL of 296 mL, the technique of intra-
corporeal cooling was successfully used to achieve repro-
ducible results [58].
Retroperitoneal route to kidney obviates the need for
bowel mobilization, and may reduce bowel related com-
plications as well as hospital stay. The approach will also
confine blood and urine leaks to retroperitoneum, and may
maximize the effectiveness of hypothermia techniques in
the limited retroperitoneal space. Our recent description of
robotic retroperitoneal partial nephrectomy, which permits
direct access to renal hilum for posterior renal and hilar
tumors is an effort in this direction [59]. A multi-centric
study by Hu et al. [60] showed retroperitoneal RAPN to
have acceptable morbidity and cancer control outcomes
over a median follow-up of 2.7 years, proving retroperito-
neal RAPN to be a reasonable option for patients with
posterior renal masses or with prior abdominal surgery.
The dissemination of partial nephrectomy has been rapid
and safe throughout theworld despite its short existence of 10
years, as evident from the published literature. In 2014, RAPN
is most common minimally invasive approach for PN, sup-
planting laparoscopy. Looking at results from nationwide in-
patients sample, patients undergoing RAPN had significantly
lower odds of receiving a blood transfusion, intraoperative or
postoperative complication, or a prolonged LOS, when
compared to open PN, and less likely to have intraoperative
complications than following laparoscopic PN [61].3.4. Reconstructive procedures
The advanced laparoscopic procedures involving recon-
struction and suturing have steep learning curve and have
remained limited to select few laparoscopic wizards and
centers around the world. Versatile instrument tip move-
ments, tremor filtering, intuitive movements and 3D vision
of robot are most suited for intracorporeal suturing and
reconstructive work. It was no surprise that all laparoscopic
reconstructive procedures were better accomplished with
the robot, and gradually shifted to robotic platform.
Laparoscopic pyeloplasty (LP), dismembered or one of
its variants, is a minimally invasive alternative for its open
counterpart with equivalent results, and became a refer-
ence standard for managing pelvi-ureteric junction
obstruction (PUJO) at turn of century. Large experiences
with robotic pyeloplasty have appeared in ensuing years.
Although long-term success rates could not be bettered,
Hemal et al. [62] reported better quality of suturing and
faster perioperative parameters of dissection time, intra-
corporeal suturing, and overall operating time using robotic
interface when compared to conventional pyeloplasty.
Sukumar and colleagues [63] found that use of minimally
invasive pyeloplasty increased dramatically from 2.4% to
55.3%, a 23-fold increase, in the United States during the
decade 1999 to 2009. Though it was not possible to
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code had not been separated till 2008, robotic pyeloplasty
was the clear winner in 2009, accounting for 45.1% of all
cases, with LP accounting for just 10.2%.
Pelvic organ prolapse (POP) affects 30% of women aged
above 50 years, and needs surgical repair in 11% by 80
years. Robotic sacrocolpopexy (RSC) became a natural
successor to its laparoscopic counterpart, as the procedure
was being performed in a limited pelvic space with need for
intracorporeal suturing. The robotic technique of sacro-
colpopexy was refined at VUI to modify the port placements
and docking identical to RARP, using a uterine positioning
system for vaginal vault adjustment instead of a sponge-
vaginal pack, a softer mesh to reduce the risk of erosion,
and a barbed continuous suture (V-Loc) for securing the
mesh and closing the peritoneal incision. The modifications
reduced operating times, LOS and intraoperative blood
transfusions during RSC [64].
Congenital anomalies of the urinary tract make a large
chunk of reconstructive urology, involving removal of whole
kidney or its part, with or without ureteric or ureterovesical
reconstruction. With its capability to work in small places
and better identification of planes (especially following
previous surgery), robot was expected to improve upon the
laparoscopy outcomes and reduce conversions. Robotic
pediatric urology program was simultaneously developed at
VUI. Small distance of abdominal wall to the target organ
was initially a challenge for pediatric robotic surgery in
infants and younger children, since it is mandatory to keep
a fixed cannula length inside the port. The problem was
sorted out by keeping the skin incisions as far away from
the operative site as possible [65]. It takes small excursions
of the robotic arm to reach different parts of peritoneal
cavity in such cases, thus avoiding collision despite
crowding. Almost all urological surgical procedures in chil-
dren have been performed with the assistance of the ro-
botic interface, most common being pyeloplasty,
nephrectomy or hemi-nephrectomy and surgery for vesico-
ureteric reflux. Initial series of advanced reconstructive
procedures like bladder augmentation and appendicovesi-
costomy are available. Although it may not yet be possible
to demonstrate the superiority of robotic approach over
conventional surgery, it is feasible, well tolerated, and
advantageous in reconstructive pediatric urological pro-
cedures [66].
3.5. Robotic kidney transplantation
Menon and colleagues at VUI conceived the idea of Robotic
Kidney Transplantation (RKT) with hypothermia in 2012 in
collaboration with Medanta Vattikuti Institute in India.
Open Renal Transplantation technique has remained un-
changed since last 60 years. Theoretically, a minimally
invasive kidney transplantation would avoid wound in-
fections, reduce complications and speed recovery, as has
been proved in every other surgical sphere so far.
Other than an early description by Abbou and coworkers
[67], where the authors performed a kidney transplantation
using articulated robotic instruments through a left lower
quadrant open incision, there were only two case reports of
RKT in literature till 2013 [68,69]. There were smallexperiences with attempts at laparoscopic recipient sur-
gery too [70]. These attempts, apart from their non-
uniform approaches, had been criticized for slow decline
of renal functions postoperatively, ascribed mainly to lack
of intracorporeal organ cooling during the anastomosis. The
technique of pelvic cooling and regional hypothermia had
been standardized at HFH using the prostatectomy model,
achieved by ice slush delivered through a GelPointª device.
Following pre-clinical studies, successful phase 1 clinical
trial of RKT with hypothermia, conducted at Medanta, India
in January 2013, proved its feasibility, with results equiv-
alent to the open surgery [71].
Seventy successful RKT have been performed till May
2014. A minimum of 6 months in 25 RKT recipients showed
mean console, arterial, and venous anastomotic times to be
135, 12, and 13.4 min, respectively. All grafts could be
maintained at 18e20 C till clamp release, without change
in core body temperature. All grafts functioned immedi-
ately post-transplant and the mean serum creatinine level
at discharge was 1.3 mg/dL. No perioperative complica-
tions, such as anastomotic leaks, wound complications, or
wound infections, were observed. At 6-month follow-up, no
patient developed a lymphocele, detected on CT scan [72].
Usefulness of RKT in morbidly obese patients, who have
traditionally not been candidates for open surgery, has also
been proved [73]. RKT, thus, seems to have a potential of
being another important robotic application in future.
3.6. Growth of robotic applications in other
specialties and around the world
The da Vinci Robot got FDA approval for gynecologic pro-
cedures in 2005. The last decade has seen a rapid increase
in use of the robot in the gynecologic world, and the related
literature. Robotic hysterectomy, myomectomy, gyneco-
logic fistula repair and transabdominal sacrocolpopexy have
shown results equivalent to open surgery. In a systematic
review of both randomized and observational studies, the
Society of Gynecologic Surgeons Systematic Review Group
found that robotic approach consistently provided shorter
hospital stay, and robotic technique was more advanta-
geous than open surgery while managing endometrial can-
cer [74].
Robotic assistance also helped video assisted thoracic
surgery (VATS) reach organs in depth of chest wall with ease
[75]. Robotic thymectomy using the thoracoscopic approach
has been accepted as technically sound and safe with very
low complication rates for the treatment of myasthenia
gravis. It was performed most frequently using the unilateral
three-trocar approach. Approximately 3500 robotic thy-
mectomy have been already registered till 2013 [76]. In a
recent review of national database, robotic assisted pul-
monary resections were associated with significant re-
ductions in mortality, hospital stay and overall complication
rates when compared with open thoracotomy [77].
Application of robotic dexterity and technology also
helped the approach to superficially placed organs where
breach of skin was to be avoided, either due to cosmetic
reasons (as for thyroidectomy and parathyroidectomy using
the bilateral axillo-breast approach) or dreaded morbidity
(as for inguinal lymphadenectomy). Trans-oral robotic
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robotic advantage in an open platform, to treat the lesions
in the skull base [78] or the depths of oral cavity [79].
Oropharynx, base of the tongue or larynx is approached
with robotic arms using one of advanced oral retractor
systems and a temporary tracheostomy. Robot with its
tremor filtration, magnified view and console ergonomics is
a wonderful tool for fine suturing alone, even in an open
platform, a fact that has found its use in the field of male
infertility, for vaso-vasostomy [80] and vaso-
epididymostomy [81], using as fine suture as 11/O.
It took nearly half a decade for the robot to travel to the
opposite part of the world, but since then, South Korea has
been quick to jump on the robotic bandwagon. Dr Rha’s
group in Korea demonstrated the safety and feasibility of
robotic laparoendoscopic single-site (LESS) partial ne-
phrectomy for renal tumors >4 cm [82]. The benefits of
robotic surgery were borne out in India too, not only for
RARP, but also for robotic pyeloplasty [83], robot-assisted
inguinal lymph node dissection for penile cancer [84], and
robotic high-intensity focused ultrasound [85].
3.7. IDEAL guidelines for pioneering surgical work
The introduction and adoption of a surgical innovation has
to be evidence based, rather than trial and error. It is also
important to derive learning curves so as to assess men-
toring requirements while disseminating a new procedure.
All robotic developments at HFH, from prostatectomy in
2000 till renal recipient surgery in 2013, have that hall-
mark, with similar design process. After conceiving a pro-
cedure, a talent pool was created for initial trials.
Development and long-term studies followed, and objec-
tive assessment of the outcome variables was done at each
step. Learning curves for surgeons with differing experi-
ences were defined during the monitoring and proctoring of
the procedure. McCullouch and colleagues [86] have
described IDEAL (innovation, development, exploration,
assessment, long-term follow-up) model for assessing and
reporting a new surgical procedure in 2009, consisting of
five-stage process. RKT has been recently innovated using
IDEAL guidelines at HFH and reported [71].
Learning curve and surgical dexterity are two parameters
that are used to compare surgical learning and training. It is
difficult to define learning curves, with varying definitions
from study to study. Studied parameters have varied from
subjective (like confidence and comfort level of operating
surgeon or self assessed study scores) to objective to reach a
proficiency limit (like number of cases required to reach a
threshold console time, OR time, or PSMs). While developing
RKT, we have used new statistical tools of cumulative sum-
mation (CUSUM) and Shewhart control chart analytic tech-
niques to monitor the patient safety and define learning
curves, respectively. These methods allow objective deter-
mination of the duration of mentorship and identification of
adverse events in a timely manner [87].
4. Conclusion
The growth of minimally invasive surgical techniques
afforded definite advantages to the surgeon and thepatient: it decreased surgical trauma and blood loss during
procedures, and hastened convalescence with better
cosmesis. This was achieved with loss of wrist movements
and ergonomics, non-intuitive movements, and downgrade
of normal vision to 2D monitors. It is not surprising that
advanced laparoscopic techniques had steep learning
curve, and remained confined to few skilled masters only.
Laparoscopy was a transition technology with tremendous
benefits, but could not prosper with so many limitations.
Robotic assistance gave laparoscopy everything back it lost,
except haptic feedback, at an additional added cost. Mani
Menon, and his team at the VUI, pioneered and helped
establish the role of robot in the field of urology. It helped
allied specialties to join in the robotic revolution.
These developments and innovations had both direct
and indirect benefits, ushering in revolutionary changes in
the specialties of urology, thoracic surgery and gynecology,
amongst others. New fields like TORS have emerged. Inno-
vative use of unidirectional barbed suture has benefitted
outcome measures in a variety of reconstructive pro-
cedures, and transformed its use profile. Use of the
GelPointª device for uninhibited access to peritoneal cavity
helped improve prostatectomy PSMs, and develop pelvic
cooling technique, which in turn paved way for pioneering
RKT with hypothermia. It also helped barbed suture and
GelPointª industry to widen indications and applications,
and flourish.
Surgical robots are here to stay. With integration of
computers, the field has become one of the front-runners in
applied research. Computer interphase has already made it
possible to integrate imaging with the current generation
robots. New robots and applications are on horizon. The
major downside of the technology is the cost. We expect
the technology to prosper and proliferate, becoming better
and cost effective in times to come. The market competi-
tion and device innovations should translate to cost effec-
tiveness and improved quality, outcome parameters and
experience for the patients.Conflicts of interest
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